Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Clinical Trials (London, England)|January 25, 2025
Pivotal trial characteristics and types of endpoints used to support Food and Drug Administration rare disease drug approvals between 2013 and 2022Kyungwan Hong, Bridget Nugent, Abbas Bandukwala, et al.
Cell Motility and the Cytoskeleton|October 6, 2005
CLAMP, a novel microtubule-associated protein with EB-type calponin homologyGerard W Dougherty, Henry J Adler, Agnieszka Rzadzinska, et al.
Oncotarget|November 18, 2015
A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistanceYongxian Ma, Anju Preet, York Tomita, et al.
The Journal of Biological Chemistry|January 31, 2006
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilizationYork Tomita, Natasha Marchenko, Susan Erster, et al.
Oncogene|January 28, 2005
Structural determinants of the BRCA1 : estrogen receptor interactionYong Xian Ma, York Tomita, Saijun Fan, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimeticsHaiying Sun, Zaneta Nikolovska-Coleska, Jianyong Chen, et al.
The Journal of Biological Chemistry|November 1, 2005
Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage displayBin Xie, Elena Tassi, Matthew R Swift, et al.
Molecular Endocrinology (Baltimore, Md.)|September 30, 2014
Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-αYongxian Ma, York Tomita, Anju Preet, et al.
Journal of the American Chemical Society|December 23, 2004
Structure-based design of potent, conformationally constrained Smac mimeticsHaiying Sun, Zaneta Nikolovska-Coleska, Chao-Yie Yang, et al.
Pageof 3